US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 29.310
- -0.950-3.14%
Close Apr 25 16:00 ET
- 28.380
- -0.930-3.17%
Post 18:08 ET
1.60BMarket Cap1465.50P/E (TTM)
30.220High29.170Low351.46KVolume30.030Open30.260Pre Close10.37MTurnover0.74%Turnover Ratio1465.50P/E (Static)54.73MShares38.09052wk High1.74P/B1.40BFloat Cap21.99052wk Low--Dividend TTM47.71MShs Float61.250Historical High--Div YieldTTM3.47%Amplitude4.300Historical Low29.499Avg Price1Lot Size
About Supernus Pharmaceuticals Company
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Company Profile
SymbolSUPN
Company NameSupernus Pharmaceuticals
Listing DateMay 1, 2012
Issue Price5.00
Founded2005
CEOMr. Jack A. Khattar
MarketNASDAQ
Employees652
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9715 Key West Avenue
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-838-2500
Websitehttp://www.supernus.com
Company Executives
- Name
- Position
- Salary
- Jack A. Khattar
- Director, President, Chief Executive Officer and Secretary
- 10.01M
- Timothy C. Dec
- Senior Vice President, Principal Accounting Officer and Chief Financial Officer
- 1.26M
- Padmanabh P. Bhatt
- Senior Vice President, Intellectual Property and Chief Scientific Officer
- 1.12M
- Dr. Jonathan Rubin, M.B.A.,M.D.
- Senior Vice President and Chief Medical Officer
- 1.25M
- Tami Tillotson Martin, Esq.,R.N.
- Senior Vice President, Regulatory Affairs
- 874.82K
- Frank Mottola
- Senior Vice President, Quality, GMP Operations and Information Technology
- 1.02M
- Charles W. Newhall, III
- Chairman of the Board
- 255.54K
- Bethany Sensenig
- Director
- --
- Dr. John M. Siebert,PhD
- Independent Director
- 255.54K
- Frederick M. Hudson
- Independent Director
- 255.54K
- Dr. Georges Gemayel,PhD
- Independent Director
- 255.54K
- Dr. Carrolee Barlow, M.D.,PhD
- Independent Director
- 255.54K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg